WO2005060667A3 - Sequences d'acides nucleiques et d'acides amines associees a la douleur - Google Patents

Sequences d'acides nucleiques et d'acides amines associees a la douleur Download PDF

Info

Publication number
WO2005060667A3
WO2005060667A3 PCT/US2004/042360 US2004042360W WO2005060667A3 WO 2005060667 A3 WO2005060667 A3 WO 2005060667A3 US 2004042360 W US2004042360 W US 2004042360W WO 2005060667 A3 WO2005060667 A3 WO 2005060667A3
Authority
WO
WIPO (PCT)
Prior art keywords
pain
nucleic acid
acid sequences
amino acid
sequences involved
Prior art date
Application number
PCT/US2004/042360
Other languages
English (en)
Other versions
WO2005060667A2 (fr
Inventor
Clifford Woolf
Urso Donatella D
Michael Costigan
Original Assignee
Gen Hospital Corp
Clifford Woolf
Urso Donatella D
Michael Costigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp, Clifford Woolf, Urso Donatella D, Michael Costigan filed Critical Gen Hospital Corp
Publication of WO2005060667A2 publication Critical patent/WO2005060667A2/fr
Priority to US11/231,114 priority Critical patent/US20060241074A1/en
Publication of WO2005060667A3 publication Critical patent/WO2005060667A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne des séquences d'acides nucléiques qui sont associées à la douleur et qui sont exprimées de manière différentielle durant la douleur. L'invention concerne également des méthodes destinées à l'identification de séquences d'acides nucléiques qui sont exprimées de manière différentielle durant la douleur, des microréseaux comprenant ces séquences exprimées de manière différentielle, ainsi que des méthodes destinées au criblage d'agents régulant l'expression de ces séquences exprimées de manière différentielle.
PCT/US2004/042360 2001-08-14 2004-12-17 Sequences d'acides nucleiques et d'acides amines associees a la douleur WO2005060667A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/231,114 US20060241074A1 (en) 2001-08-14 2005-09-20 Methods for treatment of pain

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53134103P 2003-12-19 2003-12-19
US60/531,341 2003-12-19

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/231,114 Continuation-In-Part US20060241074A1 (en) 2001-08-14 2005-09-20 Methods for treatment of pain

Publications (2)

Publication Number Publication Date
WO2005060667A2 WO2005060667A2 (fr) 2005-07-07
WO2005060667A3 true WO2005060667A3 (fr) 2009-03-19

Family

ID=34710219

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/042360 WO2005060667A2 (fr) 2001-08-14 2004-12-17 Sequences d'acides nucleiques et d'acides amines associees a la douleur

Country Status (1)

Country Link
WO (1) WO2005060667A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200140805A (ko) 2018-02-21 2020-12-16 브리스톨-마이어스 스큅 컴퍼니 Camk2d 안티센스 올리고뉴클레오티드 및 그의 용도
WO2021231211A1 (fr) 2020-05-11 2021-11-18 Genentech, Inc. Inhibiteurs de la composante c1s du complément pour le traitement d'une maladie neurologique, et compositions associées, systèmes et procédés d'utilisation de ceux-ci
JP2023525770A (ja) 2020-05-11 2023-06-19 ジェネンテック， インコーポレイテッド 神経学的疾患を処置するための補体ｃ４阻害剤および関連する組成物、ならびにそれを使用するシステムおよび方法
JP2023527693A (ja) 2020-05-11 2023-06-30 ジェネンテック， インコーポレイテッド 神経疾患を治療するための補体成分ｃ１ｒ阻害剤、並びに関連する組成物、システム、及びそれを使用する方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
REILLY ET AL.: "Discovering genes: the use ofmicroarrays and laser capture microdissection in pain research.", BRAIN RESEARCH REVIEWS., vol. 46, no. 2, October 2004 (2004-10-01), pages 225 - 233 *

Also Published As

Publication number Publication date
WO2005060667A2 (fr) 2005-07-07

Similar Documents

Publication Publication Date Title
WO2003016475A3 (fr) Sequences d'acides nucleiques et d'acides amines intervenant dans la douleur
WO2002074979A3 (fr) Profils d'expression et methodes d'utilisation
WO2005014850A3 (fr) Systemes et procedes d'analyse de sequences d'acides nucleiques
WO2005005462A3 (fr) Antagonistes de blys et leurs utilisations
WO2004074455A3 (fr) Variants de la region fc
WO2005007814A3 (fr) Mappage genomique d'elements d'adn fonctionnels et de proteines cellulaires
WO2006020768A3 (fr) Oligonucleotides chimiquement modifies
WO2006112705A3 (fr) Modulation de la reconnaissance d'exon dans un pre-arnm par interference avec la liaison de proteines sr et interference avec une structure d'arn secondaire
WO2004048551A3 (fr) Cible destinee a la therapie d'un trouble cognitif
WO2002008285A3 (fr) Molecules il-17 et leurs utilisations
AU2002365811A1 (en) Methods for the selection and cloning of nucleic acid molecules free of unwanted nucleotide sequence alterations
WO2004062475A3 (fr) Dosages fluorescents de proteines kinases
WO2004096842A3 (fr) Sequences de nucleotides et d'acides amines du virus du sras, et utilisations associees
WO2003093316A3 (fr) Molecule a reconnaissance de la surface des cellules contenant un domaine d'immunoglobuline
WO2006054297A3 (fr) Nouvelles sequences nucleotidiques et d'acides amines, et leurs dosages et leurs procedes d'utilisation pour le diagnostic
WO2006047728A3 (fr) Genes bmp et proteines de fusion
WO2007120955A3 (fr) Gènes agissant sur les performances de la mémoire humaine
WO2004094476A3 (fr) Compositions et methodes se rapportant a stop-1
WO2006066154A3 (fr) Therapie antisens a la caseine kinase 2
WO2006043060A3 (fr) Proteine contenant le domaine mam
WO2005060667A3 (fr) Sequences d'acides nucleiques et d'acides amines associees a la douleur
WO2003020887A3 (fr) Identification de genes
PL374550A1 (en) Il-17 like molecules and uses thereof
WO2001059120A3 (fr) Molecules de type il-17 et utilisation de ces dernieres
WO2004050834A3 (fr) Gpc99 et gpc99a: compositions et methodes de traitement du cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11231114

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWP Wipo information: published in national office

Ref document number: 11231114

Country of ref document: US

122 Ep: pct application non-entry in european phase